Hepatitis C Drug Research

Hepatitis C Drug Research

David Paul Morris/Bloomberg

An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. lab in Foster City, California. Gilead and Merck plan to create drug combinations in the next few years that promise to work against most forms of the disease, and take less time to do it than current therapies.